Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-03.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 82

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 83
Clinical Trial with Sulfamethoxazole-Trimethoprim (Septrin) of Shigellosis in Children

Journal of the Korean Pediatric Society 1973;16(2):137-143.
Published online February 28, 1973.
Clinical Trial with Sulfamethoxazole-Trimethoprim (Septrin) of Shigellosis in Children
Chang Yee Hong
Department of Pediatrics, College of Medicine, Seoul National University Seoul, Korea
細菌性痢疾에 대한 Sulfamethoxazole-Trimethoprim (Septrin)의 效果
서울大學校 醫科大學 小兒科學敎室
Forty-two cases of shigellosis in children were treated with sulfamethoxazole-trimethoprim (Septrin) from May 1970 to October 1972. 90% of the patients showed clinical improvement within 2 days and 40 of the 42 patients (95%) within 4 days. On the 25 strains of shigellae, in-vitro sensitivity was tested against eleven antimicrobial agents. Shigella flexneri was the most frequent organism (80%). The percentage of resistant strains to the eleven antimicrobial agents is as follows: Penicillin: 100%, Cioxacillin: 100%, Streptomycin: 92%, Chloramphenicol: 88%, Tetracycline: 88%, Kanamycin: 84%,Erythromycin: 40%,Neomycin: 32%, Ampicillin: 20%, Gentamycin: 0%, SMX/TMP (Septrin) : 0%. All strains of Shigellae tested were highly sensitive to SMX/TMP (Septrin) and Gentamycin.

METRICS Graph View
  • 919 View
  • 11 Download